FDA has approved its intravenous antihypertensive clevidipine (Cleviprex), which is the first new IV drug for high blood pressure in 10 years [1]. Clevidipine...
Many patients with heart failure would prefer to be on chronic medical therapy, which is likely to prolong survival at the cost of some quality of life, while...
The US FDA has approved the first combination of an angiotensin receptor blocker (ARB)--valsartan--with a calcium-channel blocker (CCB)--amlodipine--for the...
The combination of amlodipine and valsartan lowered blood pressure in blacks more effectively than did amlodipine monotherapy both before and after the...
US doctors have reported the first experiences of heart transplant in three infants after cardiocirculatory death, rather than brain death, in the donors [1]....
Debate is ongoing on whether use of the nucleoside reverse transcriptase inhibitors (NRTIs) abacavir (ABC) and didanosine (ddI) heightens the risk for...
A new study has found that retinopathy is associated with an increased risk of coronary heart disease (CHD) regardless of whether or not the person also has...
The addition of "high-bolus-dose" tirofiban (Aggrastat, Merck) to dual antiplatelet therapy in the prehospital setting significantly improved ST-segment...
I guess this story about a court ruling about our profesison as medical professionals whether as doctors or as clerks would sum it all up. what are your...
It's well appreciated that air pollution can worsen lung diseases and, probably through a generalized inflammatory response, cardiovascular disease as well;...
There has been a consistent push in the management of LDL cholesterol toward lower and lower levels, but there remains a significant gap in overall lipid...
A new review by three renowned experts in cardiology suggests that efforts to treat elevated cholesterol levels are not exploiting the full potential of...
Fenofibrate in combination with coenzyme Q10 (CoQ) appears to have a number of beneficial hemodynamic effects in type 2 diabetic subjects with mild left...
Patients with advanced Parkinson's disease (PD) who undergo subthalamic nucleus deep-brain stimulation (STN DBS) have an usually high rate of completed and...
Supplementation with B vitamins appears to be no better than placebo in reducing the incidence of depression or depressive symptoms, new research suggests. A...
The risk of non-traumatic lower-extremity amputation remains high among patients with type 1 diabetes, according to findings from a Swedish study published in...
Exposure to low-to-moderate levels of inorganic arsenic in drinking water and food may increase the risk of type 2 diabetes, according to data from the...
In the largest secondary stroke-prevention trial to date, the combination of aspirin and extended-release (ER) dipyridamole (Aggrenox, Boehringer Ingelheim)...
Sure to stoke the still-smoldering coals of the COURAGE debate into fresh flames, a new meta-analysis comparing PCI with medical therapy for stable coronary...
Sure to stoke the still-smoldering coals of the COURAGE debate into fresh flames, a new meta-analysis comparing PCI with medical therapy for stable coronary...
A small study in patients with virus-negative inflammatory cardiomyopathy indicates that six months of immunosuppressive therapy can improve left ventricular...
The addition of a novel factor Xa inhibitor to antiplatelet therapy resulted in a dose-dependent increase in bleeding, but there was also a trend toward a...
Another biomarker in the natriuretic peptide family may be in the offing for helping with the emergency-department diagnosis of acute heart failure. A...
A handheld device (PAS-Port, Cardica) that can create an anastomosis between a vein graft and the aorta during CABG surgery, without conventional sutures or...
A new study has shown that US hospitals participating in the American Heart Association (AHA) Get With the Guidelines--Coronary Artery Disease (GWTG-CAD)...
Austrian researchers comparing the ability of two definitions of metabolic syndrome to accurately predict the risk of developing diabetes believe that the...
Lifestyle changes, not drugs, should be the main focus for preventing type 2 diabetes: that was the conclusion of a lively debate here at the European...